Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Eckert

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Pharmacopsychiatry|August 24, 2001
Effects of hyperforin on the fluidity of brain membranesG P Eckert, W E Müller
The Journal of Nutrition, Health & Aging|April 8, 2003
Brain-membrane cholesterol in Alzheimer's diseaseG P Eckert, C Kirsch, W E Müller
Neuroreport|April 17, 2001
Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient miceG P Eckert, C Kirsch, W E Mueller
Pharmacopsychiatry|August 24, 2001
The effects of extracts from St. John's Wort and Kava Kava on brain neurotransmitter levels in the mouseN Serdarevic, G P Eckert, W E Müller
Biochemical Society Transactions|August 11, 2001
Membrane-disordering effects of beta-amyloid peptidesW E Müller, C Kirsch, G P Eckert
Pharmacopsychiatry|May 25, 1999
Piracetam: novelty in a unique mode of actionW E Müller, G P Eckert, A Eckert
Die Pharmazie|August 9, 2013
Simvastatin alters membrane cholesterol distribution and beta-amyloid levels in brains of female APP751SL miceG P Eckert, C Reik, W E Müller
Journal of Neural Transmission (Vienna, Austria : 1996)|February 1, 2005
Statins: drugs for Alzheimer's disease?G P Eckert, W G Wood, W E Müller
Journal of Neural Transmission (Vienna, Austria : 1996)|July 25, 2000
Piracetam reverses hippocampal membrane alterations in Alzheimer's diseaseG P Eckert, N J Cairns, W E Müller
Journal of Neural Transmission (Vienna, Austria : 1996)|November 22, 2001
Effects of aging and beta-amyloid on the properties of brain synaptic and mitochondrial membranesG P Eckert, W G Wood, W E Müller
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Pharmacopsychiatry|August 24, 2001
Effects of hyperforin on the fluidity of brain membranesG P Eckert, W E Müller
The Journal of Nutrition, Health & Aging|April 8, 2003
Brain-membrane cholesterol in Alzheimer's diseaseG P Eckert, C Kirsch, W E Müller
Neuroreport|April 17, 2001
Differential effects of lovastatin treatment on brain cholesterol levels in normal and apoE-deficient miceG P Eckert, C Kirsch, W E Mueller
Pharmacopsychiatry|August 24, 2001
The effects of extracts from St. John's Wort and Kava Kava on brain neurotransmitter levels in the mouseN Serdarevic, G P Eckert, W E Müller
Biochemical Society Transactions|August 11, 2001
Membrane-disordering effects of beta-amyloid peptidesW E Müller, C Kirsch, G P Eckert
Pharmacopsychiatry|May 25, 1999
Piracetam: novelty in a unique mode of actionW E Müller, G P Eckert, A Eckert
Die Pharmazie|August 9, 2013
Simvastatin alters membrane cholesterol distribution and beta-amyloid levels in brains of female APP751SL miceG P Eckert, C Reik, W E Müller
Journal of Neural Transmission (Vienna, Austria : 1996)|February 1, 2005
Statins: drugs for Alzheimer's disease?G P Eckert, W G Wood, W E Müller
Journal of Neural Transmission (Vienna, Austria : 1996)|July 25, 2000
Piracetam reverses hippocampal membrane alterations in Alzheimer's diseaseG P Eckert, N J Cairns, W E Müller
Journal of Neural Transmission (Vienna, Austria : 1996)|November 22, 2001
Effects of aging and beta-amyloid on the properties of brain synaptic and mitochondrial membranesG P Eckert, W G Wood, W E Müller
Pageof 3